MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Tokai Pharmaceuticals Company Profile (NASDAQ:TKAI)

Consensus Ratings for Tokai Pharmaceuticals (NASDAQ:TKAI) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.25 (165.52% upside)

Analysts' Ratings History for Tokai Pharmaceuticals (NASDAQ:TKAI)
Show:
DateFirmActionRatingPrice TargetActions
4/12/2016Janney Montgomery ScottReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016BMO Capital MarketsInitiated CoverageOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Bank of AmericaInitiated CoverageBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016OppenheimerReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Jefferies GroupInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014William BlairInitiated CoverageOutperform$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Stifel NicolausInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha